Abstract
IntroductionLiver disease patients undergo ‘rebalanced haemostasis’ whereby reduction in endogenous coagulation factors is offset by prothrombotic counter-effects. Targets of platelets >50x x109/L and fibrinogen >1.2g/l and use of vitamin K...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
